EU Drug Regulator Approves New Medicines Including Products From J&J and Gilead
An expert panel of the European Medicines Agency approved 12 new medicines and eight label expansions this week. Among the approvals were products from major U.S.-based pharmaceutical companies Johnson & Johnson (JNJ) and Gilead Sciences (GILD). The endorsements reflect ongoing regulatory activity in Europe for innovative drug therapies. The EU's endorsement of these drugs is a significant milestone, as it allows them to proceed toward full market authorization. These approvals may lead to increased revenue potential for the companies involved by enabling commercialization across European Union member states.
Topics: EU drug regulator European Medicines Agency pharmaceuticals